Category: Align Technology Inc.
Here's a look at some of the top legal news stories for medical device companies this week: Judge nixes alleged settlement in Stryker, Biomet poaching spat; Boston Scientific loses bids to exclude testimony in pelvic mesh trials; Occlutech claims another win over St. Jude Medical; Align Tech declares a 'total win' as federal circuit reverses ITC ruling; Report: Medtronic shareholder sues to block Covidien merger
A new Federal Circuit Court ruling means Align Technology can move forward with a patent infringement case against rival ClearCorrect.
Dental devices maker Align Technology (NSDQ:ALGN) touted a Federal Circuit Court ruling issued this month, calling it a "total win for Align."
The International Trade Commission delays its ruling on Align Technology's complaint against ClearCorrect until early April.
Align Technology (NSDQ:ALGN) said the International Trade Commission put off the target date for completing its review of a May 2013 decision that ClearCorrect infringed patents for Align's Invisalign teeth-straightening technology.
Hedge fund giant BlackRock boosted its stake in a number of medical device companies last year, but cut its holdings in others, regulatory filings show.
Wright Medical Group Inc.
, Align Technology Inc.
, ArthroCare Corp.
, AtriCure Inc.
, Biolase Technology Inc.
, BlackRock Inc.
, Cutera Inc.
, Cynosure Inc.
, Dentsply International Inc.
, HeartWare International Inc.
, ICU Medical Inc.
, Medical Action Industries Inc.
, Merit Medical Systems Inc.
, NxStage Medical Inc.
, Thoratec Corp.
Align Technology credits a 25% uptick in sales of its Invisalign clear aligner for Q4 and full-year earnings that beat Wall Street's expectations.
California's Align Technology (NSDQ:ALGN) posted some very strong numbers for its 4th quarter, boosting full-year figures beyond Wall Street's expectations.
Align Technology, its CEO and its CFO managed to dodge a federal class action lawsuit accusing them of reaping millions through insider trading while misstating the dental devices maker's financial position.
Elekta appoints former Nokia markets VP Niklas Savander as its new CEO and president.
Elekta (STO:EKTA B) said it named Niklas Savander, a former Nokia executive, as its new president & CEO. Savander is succeeding Tomas Puusepp, who will keep his seat on Stockholm-based company's board.
IT's Savander's 1st venture into the medical device industry. His resume includes stints at Hewlett-Packard as well as Nokia, according to a press release.